Phase I A study to evaluate GDC-6036 monotherapy in patients with non-small cell lung cancer (NSCLC) with KRAS G12C mutation Meeting Abstract


Authors: Sacher, A.; Patel, M. R.; Miller, W. H. Jr; Desai, J.; Garralda, E.; Bowyer, S.; Kim, T. W.; De Miguel, M.; Falcon, A.; Krebs, M. G.; Lee, J.; Cheng, M.; Han, S. W.; Shacham-Shmueli, E.; Forster, M.; Jerusalem, G.; Massarelli, E.; Rodriguez, L. P. A.; Prenen, H.; Walpole, I.; Arbour, K.; Choi, Y.; Dharia, N. V.; Lin, M.; Mandlekar, S.; Joo, S. R.; Shi, Z.; Schutzman, J.; LoRusso, P.
Abstract Title: Phase I A study to evaluate GDC-6036 monotherapy in patients with non-small cell lung cancer (NSCLC) with KRAS G12C mutation
Meeting Title: 2022 World Conference on Lung Cancer
Keywords: kras; nsclc; gdc-6036
Journal Title: Journal of Thoracic Oncology
Volume: 17
Issue: 9 Suppl.
Meeting Dates: 2022 Aug 6-9
Meeting Location: Vienna, Austria
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2022-09-01
Start Page: S8
End Page: S9
Language: English
ACCESSION: WOS:000858678100014
PROVIDER: wos
DOI: 10.1016/j.jtho.2022.07.023
Notes: Meeting Abstract: OA03.04 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kathryn Cecilia Arbour
    88 Arbour